While hypertension has been shown to be a risk factor for vascular dementia, several studies have also demonstrated that hypertension also increases the risk of Alzheimer’s disease (AD). Although the relationship between visit-to-visit blood pressure variability (VVV) and cognitive impairment, including AD, have been provided, the mechanisms remain poorly understood. This review paper focuses on the relationship of VVV with AD and summarizes the pathophysiology underlying that relationship, which appears to be mediated by arterial stiffness.
AHA: Heart Disease and Stroke Statistics-Update. 2005.
2.
RothwellPM, HowardSC, DolanE, O’BrienE, DobsonJE, DahlöfB, SeverPS, PoulterNR (2010) Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet375, 895–905.
3.
LiaoD, CooperL, CaiJ, TooleJ, BryanN, BurkeG, ShaharE, NietoJ, MosleyT, HeissG (1997) The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: The ARIC Study. Neuroepidemiology16, 149–162.
4.
NagaiM, HoshideS, IshikawaJ, ShimadaK, KarioK (2008) Ambulatory blood pressure as an independent determinant of brain atrophy and cognitive function in elderly hypertension. J Hypertens26, 1636–1641.
5.
NagaiM, HoshideS, KarioK (2010) Hypertension and dementia. Am J Hypertens23, 116–124.
6.
IadecolaC (2003) Atherosclerosis and neurodegeneration: Unexpected conspirators in Alzheimer’s dementia. Arterioscler Thromb Vasc Biol23, 1951–1953.
7.
NagaiM, HoshideS, KarioK (2013) Role of 24-hour blood pressure management in preventing kidney disease and stroke. Contrib Nephrol179, 67–80.
8.
NagaiM, KarioK (2013) Visit-to-visit blood pressure variability, silent cerebral injury, and risk of stroke. Am J Hypertens26, 1369–1376.
NagaiM, HoshideS, IshikawaJ, ShimadaK, KarioK (2012) Visit-to-visit blood pressure variations: New independent determinants for cognitive function in the elderly at high risk of cardiovascular disease. J Hypertens30, 1556–1563.
11.
SabayanB, WijsmanLW, Foster-DingleyJC, StottDJ, FordI, BuckleyBM, SattarN, JukemaJW, van OschMJ, van der GrondJ, van BuchemMA, WestendorpRG, de CraenAJ, MooijaartSP (2013) Association of visit-to-visit variability in blood pressure with cognitive function in old age: Prospective cohort study. BMJ347, f4600.
12.
AlpérovitchA, BlachierM, SoumaréA, RitchieK, DartiguesJF, Richard-HarstonS, TzourioC (2014) Blood pressure variability and risk of dementia in an elderly cohort, the Three-City Study. Alzheimers Dement10(5 Suppl), S330–337.
13.
YanoY, NingH, AllenN, ReisJP, LaunerLJ, LiuK, YaffeK, GreenlandP, Lloyd-JonesDM (2014) Long-term blood pressure variability throughout young adulthood and cognitive function in midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) study. Hypertension64, 983–988.
14.
BöhmM, SchumacherH, LeongD, ManciaG, UngerT, SchmiederR, CustodisF, DienerHC, LaufsU, LonnE, SliwaK, TeoK, FagardR, RedonJ, SleightP, AndersonC, O’DonnellM, YusufS (2015) Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk. Hypertension65, 651–661.
15.
QinB, VieraAJ, MuntnerP, PlassmanBL, EdwardsLJ, AdairLS, PopkinBM, MendezMA (2016) Visit-to-visit variability in blood pressure is related to late-life cognitive decline. Hypertension68, 106–113.
16.
WijsmanLW, de CraenAJ, MullerM, SabayanB, StottD, FordI, TrompetS, JukemaJW, WestendorpRG, MooijaartSP (2016) Blood pressure lowering medication, visit-to-visit blood pressure variability, and cognitive function in old age. Am J Hypertens29, 311–318.
17.
TullyPJ, DartiguesJF, DebetteS, HelmerC, ArteroS, TzourioC (2016) Dementia risk with antihypertensive use and blood pressure variability: A cohort study. Neurology87, 601–608.
18.
HiraiT, SasayamaS, KawasakiT, YagiS (1989) Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation80, 78–86.
19.
StörkS, van den BeldAW, von SchackyC, AngermannCE, LambertsSW, GrobbeeDE, BotsML (2004) Carotid artery plaque burden, stiffness, and mortality risk in elderly men: A prospective, population-based cohort study. Circulation110, 344–348.
20.
NagaiM, HoshideS, IshikawaJ, ShimadaK, KarioK (2011) Visit-to-visit blood pressure variations: New independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens5, 184–192.
21.
NagaiM, DoteK, KatoM, SasakiS, OdaN, KagawaE, NakanoY, YamaneA, KuboY, HigashiharaT, MiyauchiS, HaradaW, MasudaH (2017) Visit-to-visit BP variability, average BP level and carotid arterial stiffness in the elderly: A prospective study. J Hum Hypertens31, 292–298.
22.
NagaiM, DoteK, KatoM, SasakiS, OdaN, KagawaE, NakanoY, YamaneA, KuboY, HigashiharaT, MiyauchiS, HaradaW (2016) Visit-to-visit blood pressure variability and classes of antihypertensive agents; associations with artery remodeling and the risk of stroke. Curr Pharm Des22, 383–389.
23.
OkadaH, FukuiM, TanakaM, InadaS, MineokaY, NakanishiN, SenmaruT, SakabeK, UshigomeE, AsanoM, YamazakiM, HasegawaG, NakamuraN (2012) Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis220, 155–159.
24.
DiazKM, VeerabhadrappaP, KashemMA, FeairhellerDL, SturgeonKM, WilliamsonST, CrabbeDL, BrownMD (2012) Relationship of visit-to-visit and ambulatory blood pressure variability to vascular function in African Americans. Hypertens Res35, 55–61.
25.
SimboD, SheaS, McClellandRL, VieraAJ, MannD, NewmanJ, LimaJ, PolakJF, PsatyBM, MuntnerP (2013) Associations of aortic distensibility and arterial elasticity with long-term visit-to-visit blood pressure variability: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens26, 896–902.
26.
TedlaYG, YanoY, CarnethonM, GreenlandP (2017) Association between long-term blood pressure variability and 10-year progression in arterial stiffness: The Multiethnic Study of Atherosclerosis. Hypertension69, 118–127.
27.
WaldsteinSR, RiceSC, ThayerJF, NajjarSS, ScuteriA, ZondermanAB (2008) Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension51, 99–104.
28.
EliasMF, RobbinsMA, BudgeMM, AbhayaratnaWP, DoreGA, EliasPK (2009) Arterial pulse wave velocity and cognition with advancing age. Hypertension53, 668–673.
29.
HajjarI, GoldsteinFC, MartinGS, QuyyumiAA (2016) Roles of arterial stiffness and blood pressure in hypertension-associated cognitive decline in healthy adults. Hypertension67, 171–175.
30.
NagaiM, HoshideS, NishikawaM, MasahisaS, KarioK (2014) Visit-to-visit blood pressure variability in the elderly: Associations with cognitive impairment and carotid artery remodeling. Atherosclerosis233, 19–26.
31.
QiuC, von StraussE, WinbladB, FratiglioniL (2004) Decline in blood pressure over time and risk of dementia: A longitudinal study from the Kungsholmen project. Stroke35, 1810–1815.
LattanziS, LuzziS, ProvincialiL, SilvestriniM (2015) Blood pressure variability in Alzheimer’s disease and frontotemporal dementia: The effect on the rate of cognitive decline. J Alzheimers Dis45, 387–394.
36.
BlennowK, de LeonMJ, ZetterbergH (2006) Alzheimer’s disease. Lancet368, 387–403.
37.
SchneiderJA, WilsonRS, BieniasJL, EvansDA, BennettDA (2004) Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology62, 1148–1155.
38.
SnowdonDA, GreinerLH, MortimerJA, RileyKP, GreinerPA, MarkesberyWR (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA277, 813–817.
39.
ParisD, HumphreyJ, QuadrosA, PatelN, CrescentiniR, CrawfordF, MullanM (2003) Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer’s disease: Role of inflammation. Neurol Res25, 642–651.
40.
NiwaK, YounkinL, EbelingC, TurnerSK, WestawayD, YounkinS, AsheKH, CarlsonGA, IadecolaC (2000) Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc Natl Acad Sci U S A97, 9735–9740.
41.
WiesmannM, CaponeC, ZerbiV, MellendijkL, HeerschapA, ClaassenJA, KiliaanAJ (2015) Hypertension impairs cerebral blood flow in a mouse model for Alzheimer’s disease. Curr Alzheimer Res12, 914–922.
42.
WiesmannM, RoelofsM, van der LugtR, HeerschapA, KiliaanAJ, ClaassenJA (2016) Angiotensin II, hypertension, andangiotensin II receptor antagonism: Roles in the behavioural andbrain pathology of a mouse model of Alzheimer’s disease. JCereb Blood Flow Metab. doi: 10.1177/0271678X16667364
43.
WangJ, HoL, ChenL, ZhaoZ, ZhaoW, QianX, HumalaN, SerorI, BartholomewS, RosendorffC, PasinettiGM (2007) Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest117, 3393–3402.
44.
YangWN, HuXD, HanH, ShiLL, FengGF, LiuY, QianYH (2014) The effects of valsartan on cognitive deficits induced by aluminum trichloride and d-galactose in mice. Neurol Res36, 651–658.
45.
NiwaK, KazamaK, YounkinL, YounkinSG, CarlsonGA, IadecolaC (2002) Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circ Physiol283, H315–H323.
HoltzmanDM, BalesKR, TenkovaT, FaganAM, ParsadanianM, SartoriusLJ, MackeyB, OlneyJ, McKeelD, WozniakD, PaulSM (2000) Apolipoprotein E isoform-dependent amyloid deposition andneuritic degeneration in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci U S A97, 2892–2897.
48.
StamatelopoulosK, SibbingD, RallidisLS, GeorgiopoulosG, StakosD, BraunS, GatsiouA, SopovaK, KotakosC, VarounisC, TellisCC, KastritisE, AlevizakiM, TselepisAD, AlexopoulosP, LaskeC, KellerT, KastratiA, DimmelerS, ZeiherAM, StellosK (2015) Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease. J Am Coll Cardiol65, 904–916.
49.
GuptaA, IadecolaC (2015) Impaired Aβ clearance: A potential link between atherosclerosis and Alzheimer’s disease. Front Aging Neurosci7, 115.
50.
QiuC, WinbladB, ViitanenM, FratiglioniL (2003) Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: A community-based, longitudinal study. Stroke34, 594–599.
51.
NationDA, EdmondsEC, BangenKJ, Delano-WoodL, ScanlonBK, HanSD, EdlandSD, SalmonDP, GalaskoDR, BondiMW, Alzheimer’s Disease Neuroimaging Initiative Investigators (2015) Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults. JAMA Neurol72, 546–553.
52.
HanonO, HaulonS, LenoirH, SeuxML, RigaudAS, SafarM, GirerdX, ForetteF (2005) Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. Stroke36, 2193–2197.
53.
PaseMP, BeiserA, HimaliJJ, TsaoC, SatizabalCL, VasanRS, SeshadriS, MitchellGF (2016) Aortic stiffness and the risk of incident mild cognitive impairment and dementia. Stroke47, 2256–2261.
54.
HughesTM, KullerLH, Barinas-MitchellEJ, MackeyRH, McDadeEM, KlunkWE, AizensteinHJ, CohenAD, SnitzBE, MathisCA, DekoskyST, LopezOL (2013) Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults. Neurology81, 1711–1718.
55.
LilamandM, VidalJS, PlichartM, De JongLW, DuronE, HanonO (2016) Arterial stiffness and medial temporal lobe atrophy in elders with memory disorders. J Hypertens34, 1331–1337.
56.
MaillardP, MitchellGF, HimaliJJ, BeiserA, TsaoCW, PaseMP, SatizabalCL, VasanRS, SeshadriS, DeCarliC (2016) Effects of arterial stiffness on brain integrity in young adults from the Framingham Heart Study. Stroke47, 1030–1036.
HoffmanLB, SchmeidlerJ, LesserGT, BeeriMS, PurohitDP, GrossmanHT, HaroutunianV (2009) Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons. Neurology72, 1720–1726.
63.
KhachaturianAS, ZandiPP, LyketsosCG, HaydenKM, SkoogI, NortonMC, TschanzJT, MayerLS, Welsh-BohmerKA, BreitnerJC (2006) Antihypertensive medication use and incident Alzheimer disease: The Cache County Study. Arch Neurol63, 686–692.
64.
ChuangYF, BreitnerJC, ChiuYL, KhachaturianA, HaydenK, CorcoranC, TschanzJ, NortonM, MungerR, Welsh-BohmerK, ZandiPP; Cache County Investigators (2014) Use of diuretics is associated with reduced risk of Alzheimer’s disease: The Cache County Study. Neurobiol Aging35, 2429–2435.
65.
ForetteF, SeuxML, StaessenJA, ThijsL, BirkenhägerWH, BabarskieneMR, BabeanuS, BossiniA, Gil-ExtremeraB, GirerdX, LaksT, LilovE, MoisseyevV, TuomilehtoJ, VanhanenH, WebsterJ, YodfatY, FagardR (1998) Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet352, 1347–1351.
66.
ForetteF, SeuxML, StaessenJA, ThijsL, BabarskieneMR, BabeanuS, BossiniA, FagardR, Gil-ExtremeraB, LaksT, KobalavaZ, SartiC, TuomilehtoJ, VanhanenH, WebsterJ, YodfatY, BirkenhägerWH; Systolic Hypertension in Europe Investigators (2002) The prevention of dementia with antihypertensive treatment: New evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med162, 2046–2052.
67.
TomotoT, SugawaraJ, NogamiY, AonumaK, MaedaS (2015) The influence of central arterial compliance on cerebrovascular hemodynamics: Insights from endurance training intervention. J Appl Physiol (1985)119, 445–451.
68.
PantoniL (2006) White matter ischemia: Time to begin integrating experimental and clinical data. Eur Neurol56, 71–73.
69.
BrickmanAM, ReitzC, LuchsingerJA, ManlyJJ, SchupfN, MuraskinJ, DeCarliC, BrownTR, MayeuxR (2010) Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol67, 564–569.
70.
HavlikRJ, FoleyDJ, SayerB, MasakiK, WhiteL, LaunerLJ (2002) Variability in midlife systolic blood pressure is related to late-life brain white matter lesions: The Honolulu-Asia Aging study. Stroke33, 26–30.
71.
LiuW, LiuR, SunW, PengQ, ZhangW, XuE, ChengY, DingM, LiY, HongZ, WuJ, ZengJ, YaoC, HuangY, CASISP Study Group (2012) Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions. Stroke43, 2916–2922.
72.
CooperLL, WoodardT, SigurdssonS, van BuchemMA, TorjesenAA, InkerLA, AspelundT, EiriksdottirG, HarrisTB, GudnasonV, LaunerLJ, MitchellGF (2016) Cerebrovascular damage mediates relations between aortic stiffness and memory. Hypertension67, 176–182.
73.
PaseMP, HimaliJJ, MitchellGF, BeiserA, MaillardP, TsaoC, LarsonMG, DeCarliC, VasanRS, SeshadriS (2016) Association of aortic stiffness with cognition and brain aging in young and middle-aged adults: The Framingham Third Generation Cohort Study. Hypertension67, 513–519.
74.
ManciaG, DiRienzoM, ParatiG, GrassiG (1997) Sympathetic activity, blood pressure variability and end organ damage in hypertension. J Hum Hypertens11(Suppl.1), S3–S8.
75.
SpiegelK, LeproultR, Van CauterE (1999) Impact of sleep debt on metabolic and endocrine function. Lancet354, 1435–1439.
76.
NagaiK, NagaiN, ShimizuK, ChunS, NakagawaH, NiijimaA (1996) SCN output drives the autonomic nervous system: With special reference to the autonomic function related to the regulation of glucose metabolism. Prog Brain Res111, 253–272.
77.
RothwellPM (2010) Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet375, 938–948.
78.
NagaiM, HoshideS, NishikawaM, ShimadaK, KarioK (2013) Sleep duration and insomnia in the elderly: Association with blood pressure variability and carotid artery remodeling. Am J Hypertens26, 981–989.
79.
Aharon-PeretzJ, HarelT, RevachM, Ben-HaimSA (1992) Increased sympathetic and decreased parasympathetic cardiac innervation in patients with Alzheimer’s disease. Arch Neurol49, 919–922.
80.
ToledoMA, JunqueiraLFJr (2010) Cardiac autonomic modulation and cognitive status in Alzheimer’s disease. Clin Auton Res20, 11–17.
OmboniS, ParatiG, Di RienzoM, WielingW, ManciaG (1996) Blood pressure and heart rate variability in autonomic disorders: A critical review. Clin Auton Res6, 171–182.
83.
KingwellBA, CameronJD, GilliesKJ, JenningsGL, DartAM (1995) Arterial compliance may influence baroreflex function in athletes and hypertensives. Am J Physiol268, H411–418.
84.
Meel-van den AbeelenAS, LagroJ, GommerED, ReulenJP, ClaassenJA (2013) Baroreflex function is reduced in Alzheimer’s disease: A candidate biomarker?Neurobiol Aging34, 1170–1176.
85.
TzourioC, LaurentS, DebetteS (2014) Is hypertension associated with an accelerated aging of the brain?Hypertension63, 894–903.
86.
NagaiM, HoshideS, KarioK (2014) BP variability and cognitive impairment: Vascular risk factors for Alzheimer disease?Alzheimer Dis Assoc Disord28, 368.
87.
NagaiM, KarioK (2015) Visit-to-visit blood pressure variability: A possible marker of cognitive decline in Alzheimer’s disease?Neurobiol Aging36, e1.
88.
NagaiM, HoshideS, KarioK (2010) The insular cortex and cardiovascular system: A new insight into the brain-heart axis. J Am Soc Hypertens4, 174–182.
89.
RoyallDR, GaoJH, KelloggDLJr (2006) Insular Alzheimer’s disease pathology as a cause of “age-related” autonomic dysfunction and mortality in the non-demented elderly. Med Hypotheses67, 747–758.
90.
RoyallDR (2008) Insular Alzheimer disease pathology and the psychometric correlates of mortality. Cleve Clin J Med75(Suppl 2), S97–99.
91.
BraakH, BraakE (1998) Evolution of neuronal changes in the course of Alzheimer’s disease. J Neural Transm Suppl53, 127–140.
